Wendy R. Galpern

Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group

Bernard Ravina, Karen Marder, Hubert H. Fernandez et al. · Movement Disorders · 2007 · 534 citations · Full text

Medicine, Neurology, Psychiatry +17

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

M. Flint Beal, David Oakes, Ira Shoulson et al. · JAMA Neurology · 2014 · 395 citations · Full text

Medicine, Neurology, Pharmacology +17

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

David M. Frim, Tara A. Uhler, Wendy R. Galpern et al. · Proceedings of the National Academy of Sciences · 1994 · 273 citations

Life Sciences, Neurobiology, Neuroscience +17

Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data

Yin Ching I. Chen, Wendy R. Galpern, Anna‐Liisa Brownell et al. · Magnetic Resonance in Medicine · 1997 · 257 citations

Medicine, Neuroscience, Pharmacology +16

Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres

Ole Isacson, Terrence W. Deacon, Peyman Pakzaban et al. · Nature Medicine · 1995 · 225 citations

Medicine, Neurobiology, Neuroscience +13